Structure Database (LMSD)

LM_ID Common Name Systematic Name Main class Sub class Mass Formula
LMFA04010520 ent-13,20-diepi-20-J4-NeuroP (4Z,7Z,10Z)-12-((1S,5R)-5-((S,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010430 ent-13-A4-NeuroP (R,4Z,7Z,10Z,14E)-15-((1S,2S)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010206 ent-13-D4c-NeuroP (R,4Z,7Z,10Z,14E)-15-((1S,2R,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010203 ent-13-D4t-NeuroP (R,4Z,7Z,10Z,14E)-15-((1R,2S,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010334 ent-13-E4c-NeuroP (R,4Z,7Z,10Z,14E)-15-((1S,2R,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010331 ent-13-E4t-NeuroP (R,4Z,7Z,10Z,14E)-15-((1R,2S,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010078 ent-13-F4c-NeuroP (R,4Z,7Z,10Z,14E)-15-((1S,2R,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010075 ent-13-F4t-NeuroP (R,4Z,7Z,10Z,14E)-15-((1R,2S,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010494 ent-13-J4-NeuroP (R,4Z,7Z,10Z,14E)-15-((1R,5R)-5-ethyl-4-oxocyclopent-2-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010412 ent-13-epi-10-A4-NeuroP (R,4Z,7Z,11E)-10-hydroxy-12-((1R,5S)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010172 ent-13-epi-10-D4c-NeuroP (R,4Z,7Z,11E)-10-hydroxy-12-((1R,2R,5R)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010173 ent-13-epi-10-D4t-NeuroP (R,4Z,7Z,11E)-10-hydroxy-12-((1S,2S,5R)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010300 ent-13-epi-10-E4c-NeuroP (R,4Z,7Z,11E)-10-hydroxy-12-((1R,2R,3S)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010301 ent-13-epi-10-E4t-NeuroP (R,4Z,7Z,11E)-10-hydroxy-12-((1S,2S,3S)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010044 ent-13-epi-10-F4c-NeuroP (R,4Z,7Z,11E)-12-((1R,2R,3S,5R)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010045 ent-13-epi-10-F4t-NeuroP (R,4Z,7Z,11E)-12-((1S,2S,3S,5R)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010476 ent-13-epi-10-J4-NeuroP (R,4Z,7Z,11E)-10-hydroxy-12-((1S,5R)-4-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-2-en-1-yl)dodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010434 ent-13-epi-13-A4-NeuroP (S,4Z,7Z,10Z,14E)-15-((1S,2S)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010211 ent-13-epi-13-D4t-NeuroP (S,4Z,7Z,10Z,14E)-15-((1R,2S,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010214 ent-13-epi-13-D4t-NeuroP (S,4Z,7Z,10Z,14E)-15-((1S,2R,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010342 ent-13-epi-13-E4t-NeuroP (S,4Z,7Z,10Z,14E)-15-((1S,2R,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010339 ent-13-epi-13-E4t-NeuroP (S,4Z,7Z,10Z,14E)-15-((1R,2S,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010086 ent-13-epi-13-F4t-NeuroP (S,4Z,7Z,10Z,14E)-15-((1S,2R,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010083 ent-13-epi-13-F4t-NeuroP (S,4Z,7Z,10Z,14E)-15-((1R,2S,3S,5R)-2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010498 ent-13-epi-13-J4-NeuroP (S,4Z,7Z,10Z,14E)-15-((1R,5R)-5-ethyl-4-oxocyclopent-2-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010452 ent-13-epi-20-A4-NeuroP (4Z,7Z,10Z)-12-((1R,2S)-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010252 ent-13-epi-20-D4c-NeuroP (4Z,7Z,10Z)-12-((1R,2R,5R)-5-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010253 ent-13-epi-20-D4t-NeuroP (4Z,7Z,10Z)-12-((1S,2S,5R)-5-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010380 ent-13-epi-20-E4c-NeuroP (4Z,7Z,10Z)-12-((1R,2R,3S)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010381 ent-13-epi-20-E4t-NeuroP (4Z,7Z,10Z)-12-((1S,2S,3S)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010124 ent-13-epi-20-F4c-NeuroP (4Z,7Z,10Z)-12-((1R,2R,3S,5R)-3,5-dihydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010125 ent-13-epi-20-F4t-NeuroP (4Z,7Z,10Z)-12-((1S,2S,3S,5R)-3,5-dihydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010516 ent-13-epi-20-J4-NeuroP (4Z,7Z,10Z)-12-((1S,5R)-5-((R,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010438 ent-14-A4-NeuroP (Z)-6-((1S,2S)-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010222 ent-14-D4c-NeuroP (Z)-6-((1S,2R,5R)-5-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010219 ent-14-D4t-NeuroP (Z)-6-((1R,2S,5R)-5-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010350 ent-14-E4c-NeuroP (Z)-6-((1S,2R,3S)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010347 ent-14-E4t-NeuroP (Z)-6-((1R,2S,3S)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010094 ent-14-F4c-NeuroP (Z)-6-((1S,2R,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010091 ent-14-F4t-NeuroP (Z)-6-((1R,2S,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010502 ent-14-J4-NeuroP (Z)-6-((1R,5R)-5-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010442 ent-14-epi-14-A4-NeuroP (Z)-6-((1S,2S)-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopent-3-en-1-yl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010223 ent-14-epi-14-D4t-NeuroP (Z)-6-((1R,2S,5R)-5-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010226 ent-14-epi-14-D4t-NeuroP (Z)-6-((1S,2R,5R)-5-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-3-oxocyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010354 ent-14-epi-14-E4t-NeuroP (Z)-6-((1S,2R,3S)-3-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010351 ent-14-epi-14-E4t-NeuroP (Z)-6-((1R,2S,3S)-3-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010098 ent-14-epi-14-F4t-NeuroP (Z)-6-((1S,2R,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010095 ent-14-epi-14-F4t-NeuroP (Z)-6-((1R,2S,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010506 ent-14-epi-14-J4-NeuroP (Z)-6-((1R,5R)-5-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010428 ent-16-epi-13-A4-NeuroP (R,4Z,7Z,10Z,14E)-15-((1R,2S)-2-ethyl-5-oxocyclopent-3-en-1-yl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4